# Pancreatic Cancer Detection Consortium

> **NCT06388967** · — · RECRUITING · sponsor: **City of Hope Medical Center** · enrollment: 2000 (estimated)

## Conditions studied

- Pancreatic Cancer
- Pancreatic Carcinoma
- Pancreatic Adenocarcinoma
- Pancreatic Ductal Adenocarcinoma
- Pancreatic Neoplasms
- Pancreatic Cancer Stage I
- Pancreatic Cancer Stage
- Pancreatic Cancer Resectable
- Pancreatic Cancer Stage 0
- Pancreatic Cancer Stage II
- Pancreatic Cancer Stage III
- Pancreatic Cancer, Adult
- Pancreatic Cancer Non-resectable

## Interventions

- **DIAGNOSTIC_TEST:** PANcreatic cancer Exosome Early detectiON (PANXEON)

## Key facts

- **NCT ID:** NCT06388967
- **Lead sponsor:** City of Hope Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-03-15
- **Primary completion:** 2026-06-18
- **Final completion:** 2026-06-18
- **Target enrollment:** 2000 (ESTIMATED)
- **Last updated:** 2025-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06388967

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06388967, "Pancreatic Cancer Detection Consortium". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06388967. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*